Delivery Order SPE2DR25D9354-SPE2DR26FQLM9

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,729.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This delivery order, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense healthcare facilities worldwide.

DMS Pharmaceutical Group Inc. has established itself as a critical supplier within the federal pharmaceutical supply chain, with its IDC featuring a $499.9 billion ceiling value and completion date of December 31, 2036. The contract structure includes a 30-month base period followed by three 30-month option periods, enabling the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables to support recurring medical supply needs of military healthcare operations globally. The contractor's demonstrated performance across numerous delivery orders spanning diverse therapeutic categories positions it effectively as a specialized pharmaceutical supplier for Department of Defense healthcare operations.